Skip to content
Search
Search
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
Quick Exit
Home
Evidence
Hearing Day 64 Evidence
Hearing Day 64 Evidence
Evidence Information
Submission date:
15th Oct 2026
Hearing:
Hearing Day 64 – October Hearing (2026)
Submission date:
15th Oct 2026
Available Documents (18)
Filter evidence
OXHE005087_LC3.7 Oxevision Activity Tracker IFU Version 5
(PDF: 33.68 MB)
ONLINE SOURCE Regulation 2 of the Medical Devices Regulations 2002
(PDF: 8.02 MB)
NHSE028974_PS015 Email to NHSE Mental Health team sharing NRLS report following meeting
(PDF: 1.78 MB)
NHSE028965_PS013 Oxehealth response to MHRA Questions
(PDF: 8.31 MB)
NHSE028957_PS014 Emails between NHSE and MHRA regarding Oxevision responses
(PDF: 3.93 MB)
NHSE028936_PS012 Email from MHRA to NHSE re questions for Oxehealth
(PDF: 3.03 MB)
MHRA028127_First Witness Statement of Robert Reid on behalf of MHRA
(PDF: 23.17 MB)
MHRA028025_Second Witness Statement of Robert Reid
(PDF: 4.46 MB)
MHRA025474_RR1-1 Email chain requesting the Instruction For Use material for Oxehealth devices
(PDF: 8.66 MB)
MHRA025471_RR1-12 MHRA emails regarding Oxevision activity tracker
(PDF: 9.59 MB)
MHRA025464_RR1-13 Email chain between Oxehealth Chris Hannan and MHRA Hafsa Sirad regarding medical device qualification
(PDF: 11.12 MB)
MHRA025461_RR1-17 MHRA No Objection letter signed by Heloise Mignot
(PDF: 7.04 MB)
MHRA025447_RR1-2C Oxehealth Declaration of Conformity according to Medical Devices Directive
(PDF: 1.04 MB)
MHRA025443_RR1-3A NHS NRLS analysis summary regarding oxehealth and oxevision
(PDF: 15.11 MB)
MHRA025435_RR1-5A Oxehealth Response to MHRA Questions
(PDF: 15.71 MB)
MHRA025425_RR1-7 Internal MHRA emails regarding Oxehealth advertising material
(PDF: 2.31 MB)
MHRA025423_RR1-9 Internal MHRA email chain regarding reportable incident on Oxehealth
(PDF: 3.73 MB)
BSI028561_Witness Statement of Graeme Tunbridge
(PDF: 33.84 MB)
Related hearings
Hearing Day 64 – October Hearing (2026)
Hearing type:
Public Hearing
15th Oct 2026
View Hearing
Other Evidence
Hearing Day 63 Evidence
Evidence Information
Hearing:
Hearing Day 64 – October Hearing (2026)
search evidence
Search evidence
View advanced filters
Evidence submission dates
2026 (select all)
View by month
Oct 2026 (select all)
View by day
15 Oct 2026
14 Oct 2026
13 Oct 2026
12 Oct 2026
08 Oct 2026
07 Oct 2026
06 Oct 2026
05 Oct 2026
Jul 2026 (select all)
View by day
21 Jul 2026
09 Jul 2026
08 Jul 2026
07 Jul 2026
06 Jul 2026
Feb 2026 (select all)
View by day
16 Feb 2026
11 Feb 2026
10 Feb 2026
09 Feb 2026
04 Feb 2026
03 Feb 2026
02 Feb 2026
2025 (select all)
View by month
Dec 2025 (select all)
View by day
08 Dec 2025
Oct 2025 (select all)
View by day
27 Oct 2025
23 Oct 2025
22 Oct 2025
21 Oct 2025
20 Oct 2025
16 Oct 2025
15 Oct 2025
14 Oct 2025
13 Oct 2025
Jul 2025 (select all)
View by day
14 Jul 2025
10 Jul 2025
09 Jul 2025
08 Jul 2025
07 Jul 2025
May 2025 (select all)
View by day
15 May 2025
13 May 2025
12 May 2025
08 May 2025
06 May 2025
01 May 2025
Apr 2025 (select all)
View by day
30 Apr 2025
29 Apr 2025
28 Apr 2025
1999 (select all)
View by month
Dec 1999 (select all)
View by day
30 Nov 1999
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates